Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIB | hg19_v2_chr9_-_14313893_14313984 | 0.68 | 1.7e-05 | Click! |
NFIX | hg19_v2_chr19_+_13135790_13135811 | 0.46 | 7.9e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_95360983 Show fit | 14.32 |
ENST00000371464.3
|
retinol binding protein 4, plasma |
|
chr4_+_111397216 Show fit | 11.72 |
ENST00000265162.5
|
glutamyl aminopeptidase (aminopeptidase A) |
|
chr1_+_171154347 Show fit | 10.93 |
ENST00000209929.7
ENST00000441535.1 |
flavin containing monooxygenase 2 (non-functional) |
|
chr22_-_36018569 Show fit | 10.85 |
ENST00000419229.1
ENST00000406324.1 |
myoglobin |
|
chr20_+_43343886 Show fit | 10.71 |
ENST00000190983.4
|
WNT1 inducible signaling pathway protein 2 |
|
chr16_-_31439735 Show fit | 8.71 |
ENST00000287490.4
|
cytochrome c oxidase subunit VIa polypeptide 2 |
|
chr11_+_77774897 Show fit | 7.97 |
ENST00000281030.2
|
thyroid hormone responsive |
|
chr21_-_31588365 Show fit | 7.76 |
ENST00000399899.1
|
claudin 8 |
|
chr20_+_43343476 Show fit | 7.55 |
ENST00000372868.2
|
WNT1 inducible signaling pathway protein 2 |
|
chr21_-_31588338 Show fit | 7.54 |
ENST00000286809.1
|
claudin 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 39.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.8 | 26.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 23.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 20.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.2 | 20.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.5 | 20.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.6 | 19.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 18.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 16.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.6 | 15.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 166.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 112.8 | GO:0031674 | I band(GO:0031674) |
0.1 | 82.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 64.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.9 | 38.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 38.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.4 | 35.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 33.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.8 | 29.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.9 | 29.7 | GO:0032982 | myosin filament(GO:0032982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 74.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.4 | 59.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 53.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 49.7 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 45.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.3 | 39.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 30.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 28.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.7 | 24.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 23.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 202.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 132.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 29.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 23.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 22.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.8 | 21.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 19.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 17.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 17.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 16.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 49.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 38.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 36.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.2 | 35.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 35.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 28.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.5 | 26.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 26.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.5 | 22.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 19.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |